2-Isopropyl-5-methylhex-2-en-1-ol
Common Name: |
2-Isopropyl-5-methylhex-2-en-1-ol |
IUPAC Name: |
(E)-5-methyl-2-propan-2-ylhex-2-en-1-ol |
Molecular Formula: |
C10H20O |
SMILES: |
CC(C)CC=C(CO)C(C)C |
Inchi: |
1S/C10H20O/c1-8(2)5-6-10(7-11)9(3)4/h6,8-9,11H,5,7H2,1-4H3/b10-6- |
Inchi Key: |
VUGJPGPMYGKRPW-POHAHGRESA-N |
Cas No: |
40853-53-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
156.27 |
Mass (g/mol) |
156.151 |
Molar Refractivity |
50.87 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
4 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
200.00 to 201.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.077 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
2.607 |
iLOGP |
2.80 |
XLOGP3 |
3.03 |
WLOGP |
2.61 |
MLOGP |
2.70 |
ESOL Log S |
-2.45 |
ESOL Solubility (mg/ml) |
0.55 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.12 |
Ali Solubility (mg/ml) |
0.12 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.84 |
Silicos-IT Solubility (mg/ml) |
2.28 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.10 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.616 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.715 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |